Sickle cell drug tested for Long-Term safety in ongoing study
NCT ID NCT07401823
First seen Feb 12, 2026 · Last updated May 16, 2026 · Updated 16 times
Summary
This study looks at the long-term safety of a daily pill called pociredir in adults with sickle cell disease who have already seen benefits from it in a previous study. About 50 participants will take the drug for up to 48 months. The goal is to monitor side effects and check if the drug remains safe over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston Medical Center
Boston, Massachusetts, 02118, United States
-
Inova Schar Cancer Institute
Fairfax, Virginia, 22031, United States
-
Jacobi Medical Center
The Bronx, New York, 10461, United States
-
Our Lady of the Lake Hospital
Baton Rouge, Louisiana, 70808, United States
-
Queens Hospital Cancer Center
Jamaica, New York, 11432, United States
-
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
-
University of California, Los Angeles
Los Angeles, California, 90095, United States
-
University of Texas Houston
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.